Skip to main content
. 2022 Jul 5;22:32. doi: 10.1186/s40644-022-00472-4

Table 2.

Patients’ treatments and follow-up

Clinical Characteristics Patients
Neoadjuvant chemotherapy Yes 35 (92.1%)
No 3 (7.9%)
Surgery Yes 38 (100%)
No 0 (0%)
Post-operative chemotherapy Yes 37 (97.4%)
No 1 (2.6%)
Endpoint events Dead 2 (5.3%)
Recurrence or progression 17 (44.7%)
Disease free 19 (50.0%)